Home Cart 0 Sign in  
X

[ CAS No. 53939-30-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 53939-30-3
Chemical Structure| 53939-30-3
Chemical Structure| 53939-30-3
Structure of 53939-30-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 53939-30-3 ]

Related Doc. of [ 53939-30-3 ]

Alternatived Products of [ 53939-30-3 ]

Product Details of [ 53939-30-3 ]

CAS No. :53939-30-3 MDL No. :MFCD01318951
Formula : C5H3BrClN Boiling Point : -
Linear Structure Formula :- InChI Key :PEAOEIWYQVXZMB-UHFFFAOYSA-N
M.W : 192.44 Pubchem ID :2734414
Synonyms :
2-Chloro-5-bromopyridine

Calculated chemistry of [ 53939-30-3 ]

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 36.95
TPSA : 12.89 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.73 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.91
Log Po/w (XLOGP3) : 2.46
Log Po/w (WLOGP) : 2.5
Log Po/w (MLOGP) : 1.85
Log Po/w (SILICOS-IT) : 2.76
Consensus Log Po/w : 2.3

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.14
Solubility : 0.14 mg/ml ; 0.000728 mol/l
Class : Soluble
Log S (Ali) : -2.37
Solubility : 0.812 mg/ml ; 0.00422 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.5
Solubility : 0.0614 mg/ml ; 0.000319 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.6

Safety of [ 53939-30-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 53939-30-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 53939-30-3 ]
  • Downstream synthetic route of [ 53939-30-3 ]

[ 53939-30-3 ] Synthesis Path-Upstream   1~50

  • 1
  • [ 53939-30-3 ]
  • [ 78191-00-1 ]
  • [ 55676-22-7 ]
YieldReaction ConditionsOperation in experiment
84%
Stage #1: With TurboGrignard In tetrahydrofuran at 0℃; for 0.25 h; Inert atmosphere
Stage #2: at 0 - 20℃; Inert atmosphere
A round bottomed flask was charged with 5-bromo-2-chloropyridine (5.30 g, 27.6 mmol) in THF under N2 and cooled at 0° C. A solution of 1 M iso-propylmagnesiumchloride-lithium chloride complex in THF (40 mL) was added drop wise over 15 min. After 70 min N-methoxy-N-methylacetamide (4.1 mL, 38 mmol) was added drop wise. After stirring for 5 min at 0° C. the cooling bath was removed. The mixture was left stirring overnight and was then quenched by the addition of 100 mL saturated aqueous NH4Cl solution. The mixture was extracted with 3×100 mL EtOAc. The combined organic layers were washed with water followed by brine and dried over MgSO4. Evaporation of the volatiles at 80° C., 10 mbar for 1 h gave the title compound (3.596 g, 84) sufficiently pure for the next step.
Reference: [1] Patent: US2013/12530, 2013, A1, . Location in patent: Paragraph 0187
  • 2
  • [ 53939-30-3 ]
  • [ 56673-34-8 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1931, vol. 487, p. 105,115
[2] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 13, p. 3947 - 3953
  • 3
  • [ 5350-93-6 ]
  • [ 53939-30-3 ]
YieldReaction ConditionsOperation in experiment
49%
Stage #1: With hydrogen bromide In water at 20℃;
Stage #2: With sodium nitrite In water at -10℃; for 2 h;
Stage #3: With hydrogen bromide; copper(I) bromide In water at 20℃;
b) Preparation of 5 -bromo-2-chloro-pyridine. 6-Chloro-pyridin-3-ylamine (15 g, 117 mmol) was dissolved slowly with constant stirring in 48percent HBr solution (50 mL) at r.t. and then the solution was chilled to -10 °C. A solution of sodium nitrite (8.9 g, 129 mmol) in cold water (25 mL) was added dropwise at -10 °C with constant stirring over 2 h, followed by a solution of copper (I) bromide (25 g, 176 mmol) in 48percent HBr (40 mL) dropwise. The mixture was- then stirred at r.t. until complete. The mixture was neutralised with sodium carbonate and extracted with ethyl acetate. The organic phase was washed with brine, dried over soldium sulfate and concentrated. The residue was purified by column chromatography on silica gel (60-120 mesh) eluting with 1percent ethyl acetate/petroleum ether to afford 5- bromo-2-chloro-pyridine (ll.l g, 49percent).
3% With hydrogen bromide; bromine; sodium nitrite In water at -10 - 20℃; for 48 h; [5-BROMO-2-CHLOROPYRIDINE] To a solution of the available 5-amino-2-chloropyridine (3.0 g, 23.3 [MMOL)] in HBr solution 48percent [AT-10XB0;C] was added a sodium nitrite solution (4.18 g, 60.7 [MMOL)] in [WATER (6 ML). BROMINE (11.2 G, 3 EQ. ) WAS SLOWLY ADDED AND THE REACTION WAS STIRRED] at rt for 48 hours. After addition of a [NAOH] solution (16.8 [G)] in water (42 mL), and extraction with [ET20,] the organic layer was dried over [NA2SO4] and evaporated. After purification by flash chromatography using DCM/Cyclohexane 50/50 as eluent, the title compound was obtained as a white solid (0.135 g, 0.7 [MMOL)] in 3percent yield ; GC/MS: [M+C5H3BRCIN] 192
Reference: [1] Journal of Medicinal Chemistry, 2007, vol. 50, # 15, p. 3627 - 3644
[2] Patent: WO2008/62182, 2008, A1, . Location in patent: Page/Page column 119
[3] Patent: WO2004/6922, 2004, A1, . Location in patent: Page/Page column 53
[4] Zhurnal Russkago Fiziko-Khimicheskago Obshchestva, 1920, vol. 50, p. 476[5] Chem. Zentralbl., 1923, vol. 94, # III, p. 1020
  • 4
  • [ 13472-85-0 ]
  • [ 53939-30-3 ]
YieldReaction ConditionsOperation in experiment
76% With trichlorophosphate In N,N-dimethyl-formamide a
5-Bromo-2-chloro-pyridine
To a solution of 15.0 g (75.8 mmol) 5-bromo-2-methoxypyridine in 90 ml dry N,N-dimethylformamide 21.2 ml (227 mol) phosphorus oxychloride were slowly added at 0° C.
After completed addition the reaction mixture was heated to 110° C. over a period of 30 min.
At this temperature the reaction started to be exothermic.
The heating bath was partly removed such that the internal temperature did not exceed 120° C.
When the internal temperature started to drop heating was resumed, and the reaction mixture was kept at an internal temperature of 100-110° C. for 18 h.
After cooling to room temperature the reflux condenser was exchanged by a claisen condenser, and the title compound was gained as a mixture with N,N-dimethylformamide by vacuum distillation at 40-50° C. (1-10 mbar).
The distillate was diluted with cyclohexane and washed with two portions of water.
The combined aqueous layers were extracted with cyclohexane.
The combined organic extracts were dried with sodium sulfate and concentrated to give 11.0 g (76percent) of the title compound as a white solid.
MS m/e, isotope cluster (percent): 191 (M+, 75), 193 (100), 195 (24).
Reference: [1] Tetrahedron Letters, 1998, vol. 39, # 15, p. 2059 - 2062
[2] Synthetic Communications, 1990, vol. 20, # 19, p. 2971 - 2977
[3] Patent: US2002/19531, 2002, A1,
[4] Patent: US2002/40040, 2002, A1,
  • 5
  • [ 1072-97-5 ]
  • [ 53939-30-3 ]
Reference: [1] Journal of Organic Chemistry, 2008, vol. 73, # 23, p. 9326 - 9333
[2] Tetrahedron, 2004, vol. 60, # 22, p. 4861 - 4865
[3] Tetrahedron, 2002, vol. 58, # 14, p. 2885 - 2890
[4] Tetrahedron Letters, 2001, vol. 42, # 15, p. 2779 - 2781
[5] Zhurnal Russkago Fiziko-Khimicheskago Obshchestva, 1920, vol. 50, p. 489[6] Chem. Zentralbl., 1923, vol. 94, # III, p. 1021
  • 6
  • [ 5326-23-8 ]
  • [ 53939-30-3 ]
YieldReaction ConditionsOperation in experiment
45.8% With bromine; sodium hydrogencarbonate In tetrachloromethane A.
2-Chloro-5-bromopyridine
A suspension of 2 g (12 mmol) of 2-chloro-5-pyridine-carboxylic acid, 4.12 g (19 mmol) of HgO (red) and 1 ml (19 mmol) of bromine in CCl4 was irradiated (flood lamp) under reflux for 2.5 h.
The mixture was cooled to room temperature, 30 ml of sat.
sodium bicarbonate solution was added, and the mixture was stirred vigorously for 15 min.
The biphasic orange suspension was filtered through celite, the organic layer was washed with brine and dried over sodium sulfate.
The filtrate was concentrated in vacuo to afford 1.1 g (45.8percent) of 2-chloro-5-bromopyridine, as a white solid, m.p. 67°-69° C.
Reference: [1] Patent: US5618821, 1997, A,
  • 7
  • [ 2402-97-3 ]
  • [ 107-06-2 ]
  • [ 53939-30-3 ]
Reference: [1] Patent: US5502194, 1996, A,
  • 8
  • [ 13466-38-1 ]
  • [ 53939-30-3 ]
Reference: [1] Molecules, 2012, vol. 17, # 4, p. 4533 - 4544
  • 9
  • [ 4548-45-2 ]
  • [ 53939-30-3 ]
Reference: [1] Zhurnal Russkago Fiziko-Khimicheskago Obshchestva, 1920, vol. 50, p. 476[2] Chem. Zentralbl., 1923, vol. 94, # III, p. 1020
[3] Patent: WO2008/62182, 2008, A1,
  • 10
  • [ 2402-97-3 ]
  • [ 53939-30-3 ]
  • [ 52200-48-3 ]
  • [ 36953-42-1 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1988, vol. 36, p. 2244 - 2247
  • 11
  • [ 504-29-0 ]
  • [ 53939-30-3 ]
Reference: [1] Zhurnal Russkago Fiziko-Khimicheskago Obshchestva, 1920, vol. 50, p. 489[2] Chem. Zentralbl., 1923, vol. 94, # III, p. 1021
  • 12
  • [ 75-44-5 ]
  • [ 81971-39-3 ]
  • [ 53939-30-3 ]
Reference: [1] Justus Liebigs Annalen der Chemie, 1931, vol. 486, p. 71,78
  • 13
  • [ 2402-97-3 ]
  • [ 7791-25-5 ]
  • [ 53939-30-3 ]
  • [ 52200-48-3 ]
  • [ 36953-42-1 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1951, vol. 70, p. 578
  • 14
  • [ 53939-30-3 ]
  • [ 69045-79-0 ]
Reference: [1] Chemistry - A European Journal, 2010, vol. 16, # 41, p. 12425 - 12433
[2] Journal of the American Chemical Society, 2015, vol. 137, # 33, p. 10480 - 10483
  • 15
  • [ 2402-97-3 ]
  • [ 53939-30-3 ]
  • [ 52200-48-3 ]
  • [ 36953-42-1 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1988, vol. 36, p. 2244 - 2247
  • 16
  • [ 2402-97-3 ]
  • [ 7791-25-5 ]
  • [ 53939-30-3 ]
  • [ 52200-48-3 ]
  • [ 36953-42-1 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1951, vol. 70, p. 578
  • 17
  • [ 2402-97-3 ]
  • [ 53939-30-3 ]
  • [ 52200-48-3 ]
  • [ 36953-42-1 ]
Reference: [1] Chemical and Pharmaceutical Bulletin, 1988, vol. 36, p. 2244 - 2247
  • 18
  • [ 2402-97-3 ]
  • [ 7791-25-5 ]
  • [ 53939-30-3 ]
  • [ 52200-48-3 ]
  • [ 36953-42-1 ]
Reference: [1] Recueil des Travaux Chimiques des Pays-Bas, 1951, vol. 70, p. 578
  • 19
  • [ 53939-30-3 ]
  • [ 124-41-4 ]
  • [ 13472-85-0 ]
YieldReaction ConditionsOperation in experiment
33% at 90℃; for 24 h; A 0.5 M sodium methoxide methanol solution (NaOMe in MeOH, 10.4 mL, 5.19 mmol) was added to 5-bromo-2-chloropyridine (96, 500 mg, 2.59 mmol) dissolved in methanol (10 mL) at room temperature, stirred at 90° C. for 24 hours, followed by adding water. Organic compounds were extracted with ethyl acetate and evaporated after a treatment with sodium sulfate. Purification was performed by column chromatograph to give the target compound 2-methoxy-5-bromopyridine (97a, 160 mg, 33percent).1H NMR (400 MHz, CDCl3) δ 3.98 (s, 3H), 6.39 (d, J=2.4 Hz, 1H), 7.47 (dd, J=8.8, 2.4 Hz, 1H), 8.16 (d, J=2.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 14.1, 53.5, 60.3, 111.6, 112.5, 140.9, 147.4, 162.9.
Reference: [1] Patent: US2010/261727, 2010, A1, . Location in patent: Page/Page column 23
  • 20
  • [ 53939-30-3 ]
  • [ 67-56-1 ]
  • [ 13472-85-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2010, vol. 53, # 1, p. 77 - 105
  • 21
  • [ 53939-30-3 ]
  • [ 593-51-1 ]
  • [ 84539-30-0 ]
YieldReaction ConditionsOperation in experiment
27.4% at 170℃; for 4 h; Microwave irradiation A mixture of 5-bromo-2-chloropyridine (3g, 15.5 mmol), methylamine hydrochloride (3.16 g, 46.8 mmol), and DIPEA (8.17 mL, 46.8 mmol) was heated at 170°C under microwave for 4 h. The mixture was diluted with water and extracted with EtOAc. The organic layers was separated and washed with brine. Organic layer was dried over anhydrous Na2SO4 and concentrated. The residue was applied to ISCO (24g silica gel, solid loading, 70-80percent ethyl acetate/hexane) to afford 5-bromo-N-methylpyridin-2- amine (800 mg, 4.28 mmol, 27.4 percent yield) as a brown solid.
Reference: [1] Patent: WO2015/89143, 2015, A1, . Location in patent: Page/Page column 87; 88
  • 22
  • [ 53939-30-3 ]
  • [ 849937-96-8 ]
Reference: [1] Journal of Organic Chemistry, 2005, vol. 70, # 7, p. 2494 - 2502
  • 23
  • [ 53939-30-3 ]
  • [ 67-63-0 ]
  • [ 870521-31-6 ]
YieldReaction ConditionsOperation in experiment
78%
Stage #1: With sodium hydride In mineral oil at 60℃; for 0.5 h; Inert atmosphere
Stage #2: at 80℃; Reflux
General procedure: 60percent NaH in oil (1.5:1, Sodium hydride:Mineral Oil, 5.20 g) was added in two portions to isopropyl alcohol (150 mL) at room temperature under N2. The mixture was stirred at 60° C. for 30 min. 5-bromo-2-chloropyridine (10.00 g, 51.96 mmol) was added in two portions and the mixture was stirred at reflux 4 h and then at 80° C. overnight. The solution was concentrated in vacuo. Water (50 mL) and EtOAc (50 mL) was added and the layers were separated. The aqueous layer was extracted with EtOAc (50 mL). The combined organic layers were washed with brine, dried over MgSO4, filtered and the solvent was removed in vacuo. The crude product was subjected to flash chromatography (silica, 0-50percent EtOAc in heptanes) to give the title compound as a clear oil (8.74 g, 78percent). 1H NMR (600 MHz, DMSO) δ 8.17 (s, 1H), 7.61 (dd, 1H), 6.59 (d, 1H), 5.23 (m, 1H), 1.33 (s, 6H).
Reference: [1] Patent: US2013/12530, 2013, A1, . Location in patent: Paragraph 0170-0171
[2] Journal of Medicinal Chemistry, 2010, vol. 53, # 1, p. 77 - 105
  • 24
  • [ 53939-30-3 ]
  • [ 683-60-3 ]
  • [ 870521-31-6 ]
Reference: [1] Patent: WO2005/116000, 2005, A1, . Location in patent: Page/Page column 52
  • 25
  • [ 53939-30-3 ]
  • [ 6684-39-5 ]
Reference: [1] Synlett, 2011, # 8, p. 1117 - 1120
  • 26
  • [ 53939-30-3 ]
  • [ 77992-44-0 ]
YieldReaction ConditionsOperation in experiment
83% at 70℃; for 72 h; 2-Chloro-5-bromopyridine (64 g, 333 mmol) was suspended in hydrazine monohydrate (250 mL) and the mixture was heated at 70° C. for 72 hours.
The reaction mixture was then diluted with water (750 mL) and the resulting precipitate was filtered off and azeotroped, firstly with toluene (*2) then dichloromethane (*2), to afford the title compound as a pale brown solid in 83percent yield, 52 g.
83% at 70℃; for 72 h; Preparation 23: (5 -Bromopyridin -2-yl)hydrazine; 2-Chloro-5-bromopyridine (64 g, 333 mmol) was suspended in h ydrazine monohydrate (250 ml_) and the mixture was heated at 70 °C for 72 hours. The reaction mixture was then diluted with water (750 mL) and the resulting precipitate was filtered off and azeotroped, firstly with toluene (x2) then dichloromethane (x2), to afford the title compound as a paie brown solid (52 g, 83percent).
74.4% for 2 h; Inert atmosphere; Reflux a) 5-Bromo-2-hydrazinylpyridine. A mixture of 5-bromo-2-chloropyridine (11.5 g, 60 mmol) and hydrazine hydrate (100 mL) was refluxed under Argon for 2 h. The mixture was cooled to room temperature, filtered and the solids were washed with water (50 mL x 3), dried to give the title compound (8.30 g, 74.4percent yield) as yellow solids. MS: m/z 188.0 [M+H+].
74.4% for 2 h; Reflux; Inert atmosphere EXAMPLE 13-(2-Methoxyphenyl)-6-(4-methoxyphenyl)-[l,2,4]triazolo[4,3-a]pyridine a) 5-Bromo-2-hydrazinylpyridine. A mixture of 5-bromo-2-chloropyridine (11.5 g, 60 mmol) and hydrazine hydrate (100 mL) was refluxed under Argon for 2 h. The mixture was cooled to room temperature, filtered and the solids were washed with water (50 mL x 3), dried to give the title compound (8.30 g, 74.4percent yield) as yellow solids. MS: m/z 188.0 [M+H+].
44% With hydrazine hydrate In ethanol at 90℃; for 46 h; 9.3 ml (9.5 g, 190.2 mmol) hydrazine hydrate are added to a solution of 1.8 g (9.5 mmol) 5-bromo-2-chloropyridine in 25 ml ethanol at RT, while stirring, and the mixture is then stirred at 90° C. for 46 h. After concentration of the reaction mixture in vacuo, the residue is stirred in water and the solid is filtered off, washed with water and diethyl ether and dried in vacuo.Yield: 0.8 g (44percent of th.)LC-MS (Method 8): Rt=0.50 min; MS (ESIpos): m/z=188 [M+H]+;1H-NMR (400 MHz, DMSO-d6): δ=8.02 (d, 1H), 7.66 (s, 1H), 7.58 (dd, 1H), 6.69 (d, 1H), 4.16 (s, 2H).

Reference: [1] Patent: US2006/35922, 2006, A1, . Location in patent: Page/Page column 31
[2] Patent: WO2007/91152, 2007, A1, . Location in patent: Page/Page column 48
[3] Patent: WO2012/65546, 2012, A1, . Location in patent: Page/Page column 19
[4] Patent: WO2012/65297, 2012, A1, . Location in patent: Page/Page column 19
[5] Patent: US2010/305085, 2010, A1, . Location in patent: Page/Page column 17
[6] Patent: WO2012/125667, 2012, A1, . Location in patent: Page/Page column 28-29
  • 27
  • [ 53939-30-3 ]
  • [ 124-40-3 ]
  • [ 38696-21-8 ]
YieldReaction ConditionsOperation in experiment
90% at 20℃; for 5 h; 50 percent Aqueous solution of dimethylamine (30 ml) was added to 5-bromo-2-chloropyridine (1.79 g, 10 mmol) and the mixture was stirred at room temperature under argon atmosphere for 5 hrs. Saturated sodium bicarbonate solution (15 ml) was added to the reaction mixture and the mixture was extracted with ethyl acetate. The extract was washed with brine and dried. The solvent was distilled off under reduced pressure and the residue was dried at 40 °C under reduced pressure for 2 hrs. to give 5-bromo-2-dimethylaminopyrimidine (1.83 g, 90 percent) as colorless crystals. m.p.: 81 - 82°C; IR (Nujol): 1586, 1527 cm-1; APCI-MS m/z: 202/204 [M+H]+.
90% at 20℃; for 5 h; Inert atmosphere (Preparation 29) 1)
50percent Aqueous solution of dimethylamine (30 ml) was added to 5-bromo-2-chloropyridine (1.79 g, 10 mmol) and the mixture was stirred at room temperature under argon atmosphere for 5 hrs.
Saturated sodium bicarbonate solution (15 ml) was added to the reaction mixture and the mixture was extracted with ethyl acetate.
The extract was washed with brine and dried.
The solvent was distilled off under reduced pressure and the residue was dried at 40° C. under reduced pressure for 2 hrs. to give 5-bromo-2-dimethylaminopyrimidine (1.83 g, 90percent) as colorless crystals.
m.p. : 81-82° C.; IR (Nujol) : 1586, 1527 cm-1; APCI-MSm/z: 202/204 [M+H]
Reference: [1] Patent: EP1481965, 2004, A1, . Location in patent: Page 29-30
[2] Patent: EP2959918, 2015, A1, . Location in patent: Paragraph 0111
  • 28
  • [ 53939-30-3 ]
  • [ 766-11-0 ]
Reference: [1] Organic Letters, 2015, vol. 17, # 8, p. 1866 - 1869
[2] Journal of Organic Chemistry, 2015, vol. 80, # 24, p. 12137 - 12145
  • 29
  • [ 2591-86-8 ]
  • [ 53939-30-3 ]
  • [ 23100-12-1 ]
YieldReaction ConditionsOperation in experiment
68%
Stage #1: With n-butyllithium In diethyl ether; hexane at -50 - -45℃; Inert atmosphere
Stage #2: at -70 - 20℃;
5-Bromo-2-chloropyridine (T-9) (15.0 g) and diethyl ether (450 ml) were put in a reaction vessel and cooled to -50 °C under an atmosphere of nitrogen. n-Butyllithium (1.57 M in n-hexane; 54.6 ml) was added dropwise in the temperature range of -50 °C to -45 °C, and the stirring was continued for another 90 minutes. After the reaction vessel had been cooled to -70 °C, formylpiperidine (9.70 g) was added dropwise in the temperature range of -70 °C to -65 °C, and the stirring was continued for another 60 minutes while the mixture was allowed to return to room temperature. The resulting reaction mixture was poured into ice-water (500 ml) and mixed with it. Diethyl ether (200 ml) was added to the solution to separate organic and aqueous phases, and extraction was carried out. The combined organic phase was washed with water and dried over anhydrous magnesium sulfate. The resulting solution was concentrated under reduced pressure and the residue was purified with a fractional operation by means of column chromatography (silica gel; toluene). The product was further purified by recrystallization from heptane. The solvent was distilled off and the product was dried, giving 2-chloro-5-formylpyridine (T-10) (7.01 g). The yield based on the compound (T-9) was 68percent.
Reference: [1] Patent: EP2351741, 2011, A1, . Location in patent: Page/Page column 53
[2] Patent: KR101512525, 2015, B1, . Location in patent: Paragraph 0133-0135
  • 30
  • [ 53939-30-3 ]
  • [ 31301-51-6 ]
Reference: [1] Synthesis, 2010, # 14, p. 2490 - 2494
[2] Angewandte Chemie - International Edition, 2010, vol. 49, # 12, p. 2215 - 2218
  • 31
  • [ 53939-30-3 ]
  • [ 557-20-0 ]
  • [ 38749-90-5 ]
Reference: [1] Journal of Organic Chemistry, 2008, vol. 73, # 23, p. 9326 - 9333
  • 32
  • [ 53939-30-3 ]
  • [ 90196-32-0 ]
Reference: [1] Patent: CN104529881, 2017, B,
  • 33
  • [ 53939-30-3 ]
  • [ 1121-55-7 ]
  • [ 536-78-7 ]
  • [ 90196-32-0 ]
Reference: [1] Patent: CN104529881, 2017, B,
  • 34
  • [ 53939-30-3 ]
  • [ 67442-07-3 ]
  • [ 136592-00-2 ]
Reference: [1] Organic Process Research and Development, 2010, vol. 14, # 6, p. 1326 - 1336
  • 35
  • [ 53939-30-3 ]
  • [ 263012-63-1 ]
Reference: [1] Organic Letters, 2015, vol. 17, # 14, p. 3414 - 3417
  • 36
  • [ 53939-30-3 ]
  • [ 444120-91-6 ]
Reference: [1] Tetrahedron, 2002, vol. 58, # 14, p. 2885 - 2890
[2] Tetrahedron, 2004, vol. 60, # 22, p. 4861 - 4865
[3] Journal of Organic Chemistry, 2002, vol. 67, # 21, p. 7541 - 7543
[4] Journal of Medicinal Chemistry, 2005, vol. 48, # 1, p. 224 - 239
[5] Patent: EP2223912, 2010, A1, . Location in patent: Page/Page column 10
  • 37
  • [ 53939-30-3 ]
  • [ 11113-50-1 ]
  • [ 444120-91-6 ]
Reference: [1] Patent: WO2006/34440, 2006, A2, . Location in patent: Page/Page column 48
  • 38
  • [ 53939-30-3 ]
  • [ 76-09-5 ]
  • [ 444120-94-9 ]
Reference: [1] Tetrahedron, 2002, vol. 58, # 14, p. 2885 - 2890
  • 39
  • [ 53939-30-3 ]
  • [ 57260-71-6 ]
  • [ 153747-97-8 ]
YieldReaction ConditionsOperation in experiment
81.5% With potassium carbonate In acetonitrile at 110℃; for 12 h; General procedure: To 1,4-dioxane (30 mL) were added tert-butyl piperazine-1-carboxylate (2.89 g, 15.51 mmol), 5-bromo-2-chloropyrimidine (2.00 g, 10.34 mmol) and potassium carbonate (2.86 g, 20.68 mmol) sequentially. The mixture was heated to 110 °C, after stirring for 12 hours, the reaction mixture was cooled to room temperature, filtered and concentrated in vacuo. The residue was purified by silica gel chromatography (PE/EtOAc (v/v) = 20/1) to give the title compound as a pale yellow solid (3.15 g, 88.7percent).; The title compound was prepared using tert-butyl piperazine-1-carboxylate (1.45 g, 7.79 mmol),5-bromo-2-chloropyridine (1.00 g, 5.20 mmol) and potassium carbonate (1.44 g, 10.39 mmol) in acetonitrile (30 mL) according to the process described in Step 4 of Example 1, and the crude product was purified by silica gel chromatography (PE/EtOAc (v/v) = 20/1) to give the title compound as a pale yellow solid (1.45 g, 8 1.5percent).MS (ESI, pos. ion) m/z: 342.1 [M+H] and‘H NMR (600 MHz, CDC13): (ppm) 8.17 (d, J 2.4 Hz, 1H), 7.52 (dd, J 9.0, 2.5 Hz, 1H), 6.52 (d, J 9.0 Hz, 1H), 3.55 - 3.49 (m, 4H), 3.49 - 3.45 (m, 4H), 1.46 (s, 9H).
58.8% at 80℃; for 14 h; To a stirred solution of 1-Boc piperazine (10.6 g, 57.29 mmol, Symax fine chemicals) in dryDMF (lOOmL), TEA (14.43 mL, 103.39 mmol) and 5-bromo-2-chloropyrimidine (10 g, 52.08mmol, Oakwood chemicals) were added and the reaction mixture was stirred at 80°C for 14h. It was cooled down to rt and poured on iced water (100 mL). The resulting precipitatewas filtered and washed with hexane (50 mL) to afford the title compound. Yield: 58.8percent(10 g, off white solid). 1H NMR (400 MHz, DMSO-d6): 68.60(s, IH), 8.13 (dd, J= 8.6, 2.4Hz, IH), 7.54 (dd, J = 8.4, 0.4 Hz, IH), 3.22-3.20 (m, 4H), 2.61-2.59 (m, 4H), 1.42 (5, 9H).LCMS: (Method A) 343.9 (M +2H), Rt. 5.58 mm, 98.9percent (Max).
58.8% With triethylamine In N,N-dimethyl-formamide at 80℃; for 14 h; To a stirred solution of 1-Boc piperazine (10.6 g, 57.29 mmol, Symax fine chemicals) in dry DMF (100mL), TEA (14.43 mL, 103.39 mmol) and 5-bromo-2-chloropyridine (10 g, 52.08 mmol, Oakwood chemicals) were added and the reaction mixture was stirred at 80°C for 14 h. It was cooled down to rt and poured on iced water (100 mL). The resulting precipitate was filtered and washed with hexane (50 mL) to afford the title compound. Yield: 58.8percent (10 g, off white solid). 1H NMR (400 MHz, DMSO-d6): δ 8.60 (s, 1 H), 8.13 (dd, J = 8.6, 2.4 Hz, 1 H), 7.54 (dd, J = 8.4, 0.4 Hz, 1 H), 3.22-3.20 (m, 4H), 2.61 -2.59 (m, 4H), 1.42 (s, 9H). LCMS: (Method A) 343.9 (M +2H), Rt. 5.58 min, 98.9percent (Max).
Reference: [1] Patent: WO2016/192657, 2016, A1, . Location in patent: Page/Page column 65
[2] Patent: WO2017/144633, 2017, A1, . Location in patent: Page/Page column 111
[3] Patent: WO2017/144639, 2017, A1, . Location in patent: Page/Page column 96
  • 40
  • [ 53939-30-3 ]
  • [ 57260-71-6 ]
  • [ 633283-53-1 ]
  • [ 153747-97-8 ]
Reference: [1] Organic Letters, 2003, vol. 5, # 24, p. 4611 - 4614
  • 41
  • [ 53939-30-3 ]
  • [ 153747-97-8 ]
Reference: [1] Patent: US2014/364414, 2014, A1,
  • 42
  • [ 53939-30-3 ]
  • [ 74-88-4 ]
  • [ 778611-64-6 ]
Reference: [1] Synlett, 2004, # 13, p. 2319 - 2322
  • 43
  • [ 53939-30-3 ]
  • [ 74-88-4 ]
  • [ 1227402-54-1 ]
  • [ 778611-64-6 ]
Reference: [1] Journal of Organic Chemistry, 2010, vol. 75, # 10, p. 3224 - 3231
  • 44
  • [ 53939-30-3 ]
  • [ 74-88-4 ]
  • [ 1227402-54-1 ]
  • [ 778611-64-6 ]
Reference: [1] Journal of Organic Chemistry, 2010, vol. 75, # 10, p. 3224 - 3231
  • 45
  • [ 53939-30-3 ]
  • [ 823221-93-8 ]
Reference: [1] Tetrahedron, 2004, vol. 60, # 51, p. 11869 - 11874
[2] Patent: WO2017/147701, 2017, A1,
[3] Patent: WO2017/147700, 2017, A1,
  • 46
  • [ 53939-30-3 ]
  • [ 100-51-6 ]
  • [ 84611-43-8 ]
Reference: [1] Journal of Organic Chemistry, 2008, vol. 73, # 23, p. 9326 - 9333
  • 47
  • [ 53939-30-3 ]
  • [ 874959-68-9 ]
Reference: [1] Patent: WO2014/178, 2014, A1,
[2] Patent: WO2014/4416, 2014, A1,
[3] Patent: US2015/51395, 2015, A1,
[4] Patent: US2015/197531, 2015, A1,
[5] Patent: US2016/244451, 2016, A1,
[6] Journal of Medicinal Chemistry, 2017, vol. 60, # 9, p. 3795 - 3803
[7] Patent: WO2017/156181, 2017, A1,
[8] Patent: US2014/5103, 2014, A1,
  • 48
  • [ 53939-30-3 ]
  • [ 496786-98-2 ]
Reference: [1] Patent: US2014/364414, 2014, A1,
  • 49
  • [ 53939-30-3 ]
  • [ 910036-98-5 ]
Reference: [1] Patent: WO2018/111012, 2018, A1,
  • 50
  • [ 2081-44-9 ]
  • [ 53939-30-3 ]
  • [ 910036-98-5 ]
Reference: [1] Patent: US2014/121200, 2014, A1,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 53939-30-3 ]

Bromides

Chemical Structure| 29241-60-9

[ 29241-60-9 ]

5-Bromo-2-chloro-3-methylpyridine

Similarity: 0.86

Chemical Structure| 778611-64-6

[ 778611-64-6 ]

5-Bromo-2-chloro-4-methylpyridine

Similarity: 0.86

Chemical Structure| 73583-37-6

[ 73583-37-6 ]

4-Bromo-2-chloropyridine

Similarity: 0.83

Chemical Structure| 588729-99-1

[ 588729-99-1 ]

3-Amino-5-bromo-2-chloropyridine

Similarity: 0.83

Chemical Structure| 40360-47-2

[ 40360-47-2 ]

2-Chloro-3,5-dibromopyridine

Similarity: 0.81

Chlorides

Chemical Structure| 29241-60-9

[ 29241-60-9 ]

5-Bromo-2-chloro-3-methylpyridine

Similarity: 0.86

Chemical Structure| 778611-64-6

[ 778611-64-6 ]

5-Bromo-2-chloro-4-methylpyridine

Similarity: 0.86

Chemical Structure| 73583-37-6

[ 73583-37-6 ]

4-Bromo-2-chloropyridine

Similarity: 0.83

Chemical Structure| 588729-99-1

[ 588729-99-1 ]

3-Amino-5-bromo-2-chloropyridine

Similarity: 0.83

Chemical Structure| 40360-47-2

[ 40360-47-2 ]

2-Chloro-3,5-dibromopyridine

Similarity: 0.81

Related Parent Nucleus of
[ 53939-30-3 ]

Pyridines

Chemical Structure| 29241-60-9

[ 29241-60-9 ]

5-Bromo-2-chloro-3-methylpyridine

Similarity: 0.86

Chemical Structure| 778611-64-6

[ 778611-64-6 ]

5-Bromo-2-chloro-4-methylpyridine

Similarity: 0.86

Chemical Structure| 73583-37-6

[ 73583-37-6 ]

4-Bromo-2-chloropyridine

Similarity: 0.83

Chemical Structure| 588729-99-1

[ 588729-99-1 ]

3-Amino-5-bromo-2-chloropyridine

Similarity: 0.83

Chemical Structure| 40360-47-2

[ 40360-47-2 ]

2-Chloro-3,5-dibromopyridine

Similarity: 0.81